| CAS ID: | 147127-20-6 |
| Molecular Formula: | C9H14N5O4P |
| Molecular Weight: | 287.2 g/mol |
| Monoisotopic Mass: | 287.0783 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | TENOFOVIR | GS-1278 | PMPA | Tenofovir | Atripla | Truvada |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02499562 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Unknown |
| First Received | July 16, 2015 | Last Verified | July 16, 2015 |
| Sponsor | Shanghai Genomics, Inc. | ||
Trial Record 2
| ClinicalTrial ID | NCT01614405 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | June 7, 2012 | Last Verified | December 2, 2015 |
| Sponsor | University of Alberta | ||
Trial Record 3
| ClinicalTrial ID | NCT02238860 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | September 12, 2014 | Last Verified | September 12, 2014 |
| Sponsor | Asian Institute Of Medical Sciences | ||
Trial Record 4
| ClinicalTrial ID | NCT01908660 | Disease | Liver fibrosis |
| Phase | Status | Completed | |
| First Received | July 26, 2013 | Last Verified | November 11, 2015 |
| Sponsor | Valme University Hospital | ||
Trial Record 5
| ClinicalTrial ID | NCT02750059 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Active, not recruiting |
| First Received | April 25, 2016 | Last Verified | April 18, 2018 |
| Sponsor | South East Asia Research Collaboration with Hawaii | ||